期刊文献+

反义人类端粒酶RNA逆转录病毒载体构建及其对结直肠癌细胞的抑制作用 被引量:2

Construction of antisense human telomeric RNA retroviral vector and its inhibition on colorectal cancer cells
原文传递
导出
摘要 目的研究反义人类端粒酶RNA逆转录病毒载体对结直肠癌HT29细胞端粒酶活性及细胞生长的抑制作用,探讨以端粒酶为靶点的结直肠癌基因治疗的可能性。方法将端粒酶hTR的cDNA反向插入逆转录病毒载体pLXRN中,转染包装细胞PT67后获得反义重组病毒,感染结直肠癌HT29细胞。采用RT-PCR检测hTR表达,端粒酶重复扩增法(telomeraserepeatamplificationprotocol,TRAP)检测端粒酶活性,绘制生长曲线了解细胞生长状态,倒置显微镜观察和DNA片段电泳检测细胞凋亡。结果反义hTR作用后的结直肠癌细胞hTR表达下降,端粒酶活性和细胞生长受到明显抑制,细胞出现凋亡。结论反义hTR对结直肠癌HT29细胞的生长和端粒酶活性具有明显的抑制作用,有可能以hTR为靶点对结直肠癌进行基因治疗。 Objective To investigate the inhibition of telomerase activity and cellular proliferation in colorectal cancer HT29 cell lines by antisense human telomeric RNA(hTR) treatment, and explore the possibility of the telomerase as a target of gene therapy for colorectal cancer. Methods The replication deficient retrovirus expressing telomeric antisense RNA was constructed to infect the HT29 cells. hTR expression was examined by RT PCR. Telomerase activity was assayed by telomerase repeat amplification protocol (TRAP). Cell proliferation was investigated by cellular growth curve. Cellular apoptosis was detected by DNA electrophoresis method and invert microscope. Results hTR expression and telomerase activity of colorectal cancer HT29 cells were significantly inhibited, cellular proliferation were arrested, and cellular apoptosis occurred after antisense hTR transduction. Conclusions The transduction of antisense hTR by retroviral vector can significantly inhibit the hTR expression and telomerase activity of colorectal cancer HT29 cell lines, arrest the cellular proliferation and promote cellular apoptosis. The hTR may be a potential target of gene therapy for colorectal carcinoma.
出处 《中华胃肠外科杂志》 CAS 2003年第1期36-39,共4页 Chinese Journal of Gastrointestinal Surgery
基金 国家自然科学基金(39870840)
关键词 抑制作用 反义人类端粒酶RNA 端粒酶 结直肠肿瘤 Antisense Human telomeric RNA Telomerase Colorectal neoplasm
  • 相关文献

参考文献1

二级参考文献12

  • 1[1]Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer [J] .Science, 1994; 266:2011-2015
  • 2[2]Rhyu M. Telormerase, telomerase, immortality [J]. J Natl Cancer Inst, 1995, 87:885-894
  • 3[3]Hiyama E, Gollahon L, Kataoka T, et al. Telomerase activity in human breast tumors [J]. J Natl Cancer Inst, 1996, 17:116-122
  • 4[4]Shay JW, Bacchetti S. A survey of telomerase activity in human cancer [J]. EurJ Cancer, 1997,33:787-791
  • 5[5]Hiyama E, Hiyama K, Yokoyama T, et al. Correlating telomeraser activity levels with human neuroblastoma outcomes [J ]. Nature Med, 1995, ( 1 ): 249-255
  • 6[6]Engelhardt M, Drullinsky P, Guillem J. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer [J]. Clin Cancer Res, 1997, 3:1931-1941
  • 7[7]Engelhardt M, Albanell J, Drullinsky P, et al. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma [J] . Clin Cancer Res, 1997,3:1849-1857
  • 8[8]Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer [J]. Cancer Res, 1995, 55:3258-3262
  • 9[9]Blasco M, Rizen M, Greider C, et al. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis [J]. Nature Genet, 1996,12:200-204
  • 10[10]Avilion A, Piayszek A, Gupta J, et al. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues [J ].Cancer Res, 1996,56:645-650

共引文献3

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部